Header Logo

Marta Batus

Concepts (103)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
5
2016
99
1.310
Why?
Sarcoma
3
2023
59
0.720
Why?
Carcinoma, Non-Small-Cell Lung
5
2024
106
0.690
Why?
Immunotherapy
3
2021
27
0.650
Why?
Lung Neoplasms
5
2024
247
0.630
Why?
Antibodies, Monoclonal
3
2016
86
0.620
Why?
Molecular Targeted Therapy
2
2013
16
0.490
Why?
Direct-to-Consumer Advertising
1
2016
1
0.480
Why?
Medical Oncology
1
2016
23
0.470
Why?
Melanoma
1
2013
34
0.380
Why?
Bone Neoplasms
1
2013
59
0.380
Why?
Neutrophils
2
2023
58
0.220
Why?
Humans
13
2024
12240
0.220
Why?
Body Composition
1
2024
43
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2015
105
0.200
Why?
Sarcoma, Synovial
1
2022
7
0.180
Why?
Antineoplastic Agents, Immunological
1
2021
11
0.160
Why?
Autoantibodies
1
2021
29
0.160
Why?
Biomarkers, Tumor
1
2021
101
0.160
Why?
Adenocarcinoma
2
2018
61
0.150
Why?
Carcinoma, Squamous Cell
2
2018
70
0.140
Why?
Erlotinib Hydrochloride
1
2018
7
0.140
Why?
Inflammation Mediators
1
2018
37
0.130
Why?
Drug Resistance, Neoplasm
1
2018
42
0.130
Why?
Biomarkers
1
2018
294
0.120
Why?
Chemoradiotherapy
1
2015
17
0.120
Why?
Prognosis
3
2023
363
0.110
Why?
Neoplasm Metastasis
2
2013
53
0.110
Why?
Neoplasms
1
2016
94
0.110
Why?
Retrospective Studies
4
2023
1467
0.110
Why?
Adult
3
2022
3557
0.100
Why?
Cancer Vaccines
1
2013
3
0.100
Why?
Angiogenesis Inhibitors
1
2013
10
0.100
Why?
Receptor, IGF Type 1
1
2013
12
0.100
Why?
Forecasting
1
2013
36
0.100
Why?
United States
1
2016
989
0.090
Why?
Neoplasm Staging
2
2024
168
0.090
Why?
Child, Preschool
1
2013
320
0.090
Why?
Female
7
2024
6974
0.090
Why?
Middle Aged
5
2024
4043
0.090
Why?
Male
6
2024
6815
0.080
Why?
Child
1
2013
614
0.080
Why?
Body Weight
2
2024
72
0.080
Why?
Aged
4
2024
4000
0.080
Why?
Rectal Neoplasms
1
2010
6
0.080
Why?
Pyrimidines
1
2010
16
0.080
Why?
Gastrointestinal Stromal Tumors
1
2010
13
0.080
Why?
Lymphocytes
2
2023
30
0.080
Why?
Young Adult
1
2013
863
0.080
Why?
Adolescent
1
2013
989
0.080
Why?
Piperazines
1
2010
41
0.080
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
7
0.070
Why?
Prospective Studies
2
2023
817
0.070
Why?
Animals
1
2013
2092
0.070
Why?
Chromosomes, Human, Pair 10
1
2007
4
0.060
Why?
Chromosomes, Human, Pair 3
1
2007
5
0.060
Why?
Chromosomes, Human, Pair 1
1
2007
4
0.060
Why?
Receptor, ErbB-2
1
2007
32
0.060
Why?
Breast Neoplasms
1
2007
195
0.050
Why?
Treatment Outcome
2
2021
1478
0.050
Why?
Body Mass Index
1
2024
221
0.050
Why?
Lymphocyte Count
1
2023
10
0.050
Why?
Tumor Microenvironment
1
2023
12
0.050
Why?
Follow-Up Studies
2
2018
726
0.050
Why?
Margins of Excision
1
2022
16
0.040
Why?
B7-H1 Antigen
1
2021
4
0.040
Why?
Programmed Cell Death 1 Receptor
1
2021
9
0.040
Why?
Antigens, Neoplasm
1
2021
22
0.040
Why?
Observer Variation
1
2021
47
0.040
Why?
Survival Analysis
1
2021
99
0.040
Why?
Patient Selection
1
2021
111
0.040
Why?
Time Factors
1
2022
695
0.040
Why?
Aged, 80 and over
2
2018
2152
0.040
Why?
Carcinoma, Large Cell
1
2018
7
0.030
Why?
ErbB Receptors
1
2018
31
0.030
Why?
Protein Kinase Inhibitors
1
2018
29
0.030
Why?
Proteomics
1
2018
39
0.030
Why?
Survival Rate
1
2018
152
0.030
Why?
Mutation
1
2018
175
0.030
Why?
Leukocyte Count
1
2017
35
0.030
Why?
Kaplan-Meier Estimate
1
2017
85
0.030
Why?
Radiation Pneumonitis
1
2015
2
0.030
Why?
Pemetrexed
1
2015
4
0.030
Why?
Hemoptysis
1
2015
4
0.030
Why?
Esophagitis
1
2015
5
0.030
Why?
Etoposide
1
2015
15
0.030
Why?
Carboplatin
1
2015
11
0.030
Why?
Chest Pain
1
2015
8
0.030
Why?
Cough
1
2015
7
0.030
Why?
Paclitaxel
1
2015
25
0.030
Why?
Radiation Injuries
1
2015
15
0.030
Why?
Dyspnea
1
2015
22
0.030
Why?
Palliative Care
1
2015
53
0.030
Why?
Cohort Studies
1
2015
827
0.020
Why?
Imatinib Mesylate
1
2010
4
0.020
Why?
Benzamides
1
2010
8
0.020
Why?
Colectomy
1
2010
10
0.020
Why?
Neoadjuvant Therapy
1
2010
23
0.020
Why?
Biopsy
1
2010
97
0.020
Why?
Tomography, X-Ray Computed
1
2010
281
0.020
Why?
Fatal Outcome
1
2008
28
0.020
Why?
Trastuzumab
1
2007
16
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2007
40
0.020
Why?
Batus's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (103)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_